The Role and Application of Salivary Exosomes in Malignant Neoplasms

References

• Pilleron S, Sarfati D, Janssen-Heijnen M, et al. Global cancer incidence in older adults, 2012 and 2035: a population-based study. Int J Cancer. 2019;144(1):49–58. doi:10.1002/ijc.3166429978474
   PubMed Web of Science ®Google Scholar
• Pedersen AML, Sørensen CE, Proctor GB, Carpenter GH, Ekström J. Salivary secretion in health and disease. J Oral Rehabil. 2018;45(9):730–746. doi:10.1111/joor.1266429878444
   PubMed Web of Science ®Google Scholar
• Han Y, Jia L, Zheng Y, Li W. Salivary exosomes: emerging roles in systemic disease. Int J Biol Sci. 2018;14(6):633–643. doi:10.7150/ijbs.2501829904278
   PubMed Web of Science ®Google Scholar
• Raab-Traub N, Dittmer DP. Viral effects on the content and function of extracellular vesicles. Nat Rev Microbiol. 2017;15(9):559–572. doi:10.1038/nrmicro.2017.6028649136
   PubMed Web of Science ®Google Scholar
• Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). The Journal of Biological Chemistry. 1987;262(19):9412–9420. doi:10.1016/S0021-9258(18)48095-7.
   Google Scholar
• Latifkar A, Cerione RA, Antonyak MA. Probing the mechanisms of extracellular vesicle biogenesis and function in cancer. Biochem Soc Trans. 2018;46(5):1137–1146. doi:10.1042/BST2018052330301841
   PubMed Web of Science ®Google Scholar
• Wu M, Ouyang Y, Wang Z, et al. Isolation of exosomes from whole blood by integrating acoustics and microfluidics. Proc Natl Acad Sci U S A. 2017;114(40):10584–10589. doi:10.1073/pnas.170921011428923936
   PubMed Web of Science ®Google Scholar
• Spaull R, McPherson B, Gialeli A, et al. Exosomes populate the cerebrospinal fluid of preterm infants with post-haemorrhagic hydrocephalus. Int J Develop Neurosc. 2019;73:59–65. doi:10.1016/j.ijdevneu.2019.01.004
   PubMed Web of Science ®Google Scholar
• Street JM, Koritzinsky EH, Glispie DM, Yuen PST. Urine exosome isolation and characterization. Methods Mol Biol. 2017;1641:413–423.28748478
   PubMedGoogle Scholar
• Cheshmi B, Cheshomi H. Salivary exosomes: properties, medical applications, and isolation methods. Mol Biol Rep. 2020;47(8):6295–6307. doi:10.1007/s11033-020-05659-132676813
   PubMed Web of Science ®Google Scholar
• Zheng X, Chen F, Zhang J, Zhang Q, Lin J. Exosome analysis: a promising biomarker system with special attention to saliva. J Membr Biol. 2014;247(11):1129–1136. doi:10.1007/s00232-014-9717-125135166
   PubMed Web of Science ®Google Scholar
• Fu W, Lei C, Liu S, et al. CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity. Nat Commun. 2019;10(1):4355. doi:10.1038/s41467-019-12321-331554797
   PubMed Web of Science ®Google Scholar
• Li J, Peng K, Li Y, et al. Exosome-mimetic supramolecular vesicles with reversible and controllable fusion and fission. Angew Chem Int Ed Engl. 2020;59(48):21510–21514. doi:10.1002/anie.20201025732779357
   PubMed Web of Science ®Google Scholar
• Wang J, Dong Y, Li Y, et al. Designer exosomes for active targeted chemo-photothermal synergistic tumor therapy. Adv Funct Mater. 2018;28(18):1707360. doi:10.1002/adfm.201707360
   Web of Science ®Google Scholar
• Nonaka T, Wong DTW. Saliva-exosomics in cancer: molecular characterization of cancer-derived exosomes in saliva. The Enzymes. 2017;42:125–151.29054268
   PubMedGoogle Scholar
• Nguyen VVT, Witwer KW, Verhaar MC, Strunk D, van Balkom BWM. Functional assays to assess the therapeutic potential of extracellular vesicles. J Extracellular Vesicles. 2020;10(1):e12033. doi:10.1002/jev2.1203333708360
   PubMed Web of Science ®Google Scholar
• Ferreira AF, Calin GA, Picanço-Castro V, Kashima S, Covas DT, de Castro FA. Hematopoietic stem cells from induced pluripotent stem cells - considering the role of microRNA as a cell differentiation regulator. J Cell Sci. 2018;131(4):jcs203018. doi:10.1242/jcs.20301829467236
   PubMed Web of Science ®Google Scholar
• Palanisamy V, Sharma S, Deshpande A, Zhou H, Gimzewski J, Wong DT. Nanostructural and transcriptomic analyses of human saliva derived exosomes. PLoS One. 2010;5(1):e8577. doi:10.1371/journal.pone.000857720052414
   PubMed Web of Science ®Google Scholar
• Zlotogorski-Hurvitz A, Dayan D, Chaushu G, et al. Human saliva-derived exosomes: comparing methods of isolation. J Histochem Cytochem. 2015;63(3):181–189. doi:10.1369/002215541456421925473095
   PubMed Web of Science ®Google Scholar
• Shao H, Im H, Castro CM, Breakefield X, Weissleder R, Lee H. New technologies for analysis of extracellular vesicles. Chem Rev. 2018;118(4):1917–1950. doi:10.1021/acs.chemrev.7b0053429384376
   PubMed Web of Science ®Google Scholar
• Li P, Kaslan M, Lee SH, Yao J, Gao Z. Progress in exosome isolation techniques. Theranostics. 2017;7(3):789–804. doi:10.7150/thno.1813328255367
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhu Q, Cheng L, et al. Exosome detection via the ultrafast-isolation system: EXODUS. Nat Methods. 2021;18(2):212–218. doi:10.1038/s41592-020-01034-x33432243
   PubMed Web of Science ®Google Scholar
• Kim H, Lee JW, Han G, Kim K, Yang Y, Kim SH. Extracellular vesicles as potential theranostic platforms for skin diseases and aging. Pharmaceutics. 2021;13(5):760. doi:10.3390/pharmaceutics1305076034065468
   PubMed Web of Science ®Google Scholar
• Zheng X, Chen F, Zhang Q, et al. Salivary exosomal PSMA7: a promising biomarker of inflammatory bowel disease. Protein Cell. 2017;8(9):686–695. doi:10.1007/s13238-017-0413-728523434
   PubMed Web of Science ®Google Scholar
• Han P, Bartold PM, Salomon C, Ivanovski S. Salivary outer membrane vesicles and DNA methylation of small extracellular vesicles as biomarkers for periodontal status: a pilot study. Int J Mol Sci. 2021;22(5):2423. doi:10.3390/ijms2205242333670900
   PubMed Web of Science ®Google Scholar
• Byun JS, Hong SH, Choi JK, Jung JK, Lee HJ. Diagnostic profiling of salivary exosomal microRNAs in oral lichen planus patients. Oral Dis. 2015;21(8):987–993. doi:10.1111/odi.1237426389700
   PubMed Web of Science ®Google Scholar
• Melo SA, Luecke LB, Kahlert C, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 2015;523(7559):177–182. doi:10.1038/nature1458126106858
   PubMed Web of Science ®Google Scholar
• Tang MK, Wong AS. Exosomes: emerging biomarkers and targets for ovarian cancer. Cancer Lett. 2015;367(1):26–33. doi:10.1016/j.canlet.2015.07.01426189430
   PubMed Web of Science ®Google Scholar
• Kholia S, Ranghino A, Garnieri P, et al. Extracellular vesicles as new players in angiogenesis. Vascul Pharmacol. 2016;86:64–70. doi:10.1016/j.vph.2016.03.00527013016
   PubMed Web of Science ®Google Scholar
• Dong X, Bai X, Ni J, et al. Exosomes and breast cancer drug resistance. Cell Death Dis. 2020;11(11):987. doi:10.1038/s41419-020-03189-z33203834
   PubMed Web of Science ®Google Scholar
• Ye L, Zhang Q, Cheng Y, et al. Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1(+) regulatory B cell expansion. J Immunother Cancer. 2018;6(1):145. doi:10.1186/s40425-018-0451-630526680
   PubMed Web of Science ®Google Scholar
• Zhou C, Wei W, Ma J, et al. Cancer-secreted exosomal miR-1468-5p promotes tumor immune escape via the immunosuppressive reprogramming of lymphatic vessels. Mol Ther. 2021;29(4):1512–1528. doi:10.1016/j.ymthe.2020.12.03433388421
   PubMed Web of Science ®Google Scholar
• Pi F, Binzel DW, Lee TJ, et al. Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression. Nat Nanotechnol. 2018;13(1):82–89. doi:10.1038/s41565-017-0012-z29230043
   PubMed Web of Science ®Google Scholar
• Siravegna G, Marsoni S, Siena S, Bardelli A. Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol. 2017;14(9):531–548. doi:10.1038/nrclinonc.2017.1428252003
   PubMed Web of Science ®Google Scholar
• Nonaka T, Wong DTW. Liquid biopsy in head and neck cancer: promises and challenges. J Dent Res. 2018;97(6):701–708. doi:10.1177/002203451876207129513618
   PubMed Web of Science ®Google Scholar
• Wang Y, Springer S, Mulvey CL, et al. Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas. Sci Transl Med. 2015;7(293):293ra104. doi:10.1126/scitranslmed.aaa8507
   PubMed Web of Science ®Google Scholar
• Langevin S, Kuhnell D, Parry T, et al. Comprehensive microRNA-sequencing of exosomes derived from head and neck carcinoma cells in vitro reveals common secretion profiles and potential utility as salivary biomarkers. Oncotarget. 2017;8(47):82459–82474. doi:10.18632/oncotarget.1961429137278
   PubMedGoogle Scholar
• Cai J, Qiao B, Gao N, Lin N, He W. Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p. Am J Physiol Cell Physiol. 2019;316(5):C731–c740. doi:10.1152/ajpcell.00366.201830811223
   PubMed Web of Science ®Google Scholar
• Liu CJ, Lin SC, Yang CC, Cheng HW, Chang KW. Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma. Head Neck. 2012;34(2):219–224. doi:10.1002/hed.2171322083872
   PubMed Web of Science ®Google Scholar
• Lin Y, Dong H, Deng W, et al. Evaluation of salivary exosomal chimeric GOLM1-NAA35 RNA as a potential biomarker in Esophageal carcinoma. Clin Cancer Res. 2019;25(10):3035–3045. doi:10.1158/1078-0432.CCR-18-316930745298
   PubMed Web of Science ®Google Scholar
• Zhang L, Xiao H, Karlan S, et al. Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer. PLoS One. 2010;5(12):e15573. doi:10.1371/journal.pone.001557321217834
   PubMed Web of Science ®Google Scholar
• Dalla PV, Santos J, Milthorpe BK, Padula MP. Selectively-packaged proteins in breast cancer extracellular vesicles involved in metastasis. Int J Mol Sci. 2020;21(14):4990. doi:10.3390/ijms21144990
   PubMed Web of Science ®Google Scholar
• Lau C, Kim Y, Chia D, et al. Role of pancreatic cancer-derived exosomes in salivary biomarker development. J Biol Chem. 2013;288(37):26888–26897. doi:10.1074/jbc.M113.45245823880764
   PubMed Web of Science ®Google Scholar
• Sun Y, Huo C, Qiao Z, et al. Comparative proteomic analysis of exosomes and microvesicles in human saliva for lung cancer. J Proteome Res. 2018;17(3):1101–1107. doi:10.1021/acs.jproteome.7b0077029397740
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu S, Qiao Z, et al. Systematic comparison of exosomal proteomes from human saliva and serum for the detection of lung cancer. Anal Chim Acta. 2017;982:84–95. doi:10.1016/j.aca.2017.06.00528734369
   PubMed Web of Science ®Google Scholar
• Ullah M, Kodam SP, Mu Q, Akbar A. Microbubbles versus extracellular vesicles as therapeutic cargo for targeting drug delivery. ACS Nano. 2021;15(3):3612–3620. doi:10.1021/acsnano.0c1068933666429
   PubMed Web of Science ®Google Scholar
• Zhu L, Chen L. Progress in research on paclitaxel and tumor immunotherapy. Cell Mol Biol Lett. 2019;24:40. doi:10.1186/s11658-019-0164-y31223315
   PubMed Web of Science ®Google Scholar
• Kim MS, Haney MJ, Zhao Y, et al. Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations. Nanomedicine. 2018;14(1):195–204. doi:10.1016/j.nano.2017.09.01128982587
   PubMed Web of Science ®Google Scholar
• Ma J, Zhang Y, Tang K, et al. Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles. Cell Res. 2016;26(6):713–727. doi:10.1038/cr.2016.5327167569
   PubMed Web of Science ®Google Scholar
• Aslan C, Kiaie SH, Zolbanin NM, et al. Exosomes for mRNA delivery: a novel biotherapeutic strategy with hurdles and hope. BMC Biotechnol. 2021;21(1):20. doi:10.1186/s12896-021-00683-w33691652
   PubMed Web of Science ®Google Scholar
• Marar C, Starich B, Wirtz D. Extracellular vesicles in immunomodulation and tumor progression. Nat Immunol. 2021;22(5):560–570. doi:10.1038/s41590-021-00899-033753940
   PubMed Web of Science ®Google Scholar
• Salazar C, Nagadia R, Pandit P, et al. A novel saliva-based microRNA biomarker panel to detect head and neck cancers. Cellular Oncol. 2014;37(5):331–338. doi:10.1007/s13402-014-0188-2
   PubMed Web of Science ®Google Scholar
• Baroni S, Romero-Cordoba S, Plantamura I, et al. Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts. Cell Death Dis. 2016;7(7):e2312. doi:10.1038/cddis.2016.22427468688
   PubMed Web of Science ®Google Scholar
• Li L, Lu S, Liang X, et al. γδTDEs: an efficient delivery system for miR-138 with anti-tumoral and immunostimulatory roles on oral squamous cell carcinoma. Mol Ther Nucleic Acids. 2019;14:101–113. doi:10.1016/j.omtn.2018.11.00930594069
   PubMedGoogle Scholar
• Hayashi T, Lombaert IM, Hauser BR, Patel VN, Hoffman MP. Exosomal MicroRNA transport from salivary mesenchyme regulates epithelial progenitor expansion during organogenesis. Dev Cell. 2017;40(1):95–103. doi:10.1016/j.devcel.2016.12.00128041903
   PubMed Web of Science ®Google Scholar
• Xu Z, Zeng S, Gong Z, Yan Y. Exosome-based immunotherapy: a promising approach for cancer treatment. Mol Cancer. 2020;19(1):160. doi:10.1186/s12943-020-01278-333183286
   PubMed Web of Science ®Google Scholar
• Naseri M, Bozorgmehr M, Zöller M, Ranaei Pirmardan E, Madjd Z. Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy. Oncoimmunology. 2020;9(1):1779991. doi:10.1080/2162402X.2020.177999132934883
   PubMed Web of Science ®Google Scholar
• Wang M, Zhao J, Zhang L, et al. Role of tumor microenvironment in tumorigenesis. J Cancer. 2017;8(5):761–773. doi:10.7150/jca.1764828382138
   PubMed Web of Science ®Google Scholar
• Jiang L, Yang W, Bian W, et al. MicroRNA-623 targets cyclin D1 to inhibit cell proliferation and enhance the chemosensitivity of cells to 5-Fluorouracil in gastric cancer. Oncol Res. 2018;27(1):19–27. doi:10.3727/096504018X1519346924050829495973
   PubMed Web of Science ®Google Scholar
• Panarese I, Aquino G, Ronchi A, et al. Oral and oropharyngeal squamous cell carcinoma: prognostic and predictive parameters in the etiopathogenetic route. Expert Rev Anticancer Ther. 2019;19(2):105–119. doi:10.1080/14737140.2019.156128830582397
   PubMed Web of Science ®Google Scholar
• Gai C, Camussi F, Broccoletti R, et al. Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma. BMC Cancer. 2018;18(1):439. doi:10.1186/s12885-018-4364-z29669525
   PubMed Web of Science ®Google Scholar
• Li L, Li C, Wang S, et al. Exosomes derived from hypoxic oral squamous cell carcinoma cells deliver miR-21 to normoxic cells to elicit a prometastatic phenotype. Cancer Res. 2016;76(7):1770–1780. doi:10.1158/0008-5472.CAN-15-162526992424
   PubMed Web of Science ®Google Scholar
• He L, Ping F, Fan Z. Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2020;121:109553. doi:10.1016/j.biopha.2019.10955331704611
   PubMed Web of Science ®Google Scholar
• Wang C, Niu Y, Ma C, Gong Z, Liu H. Salivary adenoid cystic carcinoma-derived exosomes promote the proliferation, migration and invasion of cancer cells. Modern Oncol. 2020;28:1067–1071.
   Google Scholar
• Zhang L, Zhen Q, Zhan L. StudyontheeffectofexosomemiR-512-3pontheproliferationoftongue squamouscellcarcinomacelllinesbydown-regulatingGas2. Chongqing Med. 2020;49:3709–3713.
   Google Scholar
• Katsiougiannis S, Chia D, Kim Y, Singh RP, Wong DT. Saliva exosomes from pancreatic tumor-bearing mice modulate NK cell phenotype and antitumor cytotoxicity. FASEB J. 2017;31(3):998–1010. doi:10.1096/fj.201600984R27895106
   PubMed Web of Science ®Google Scholar
• Chen X, Li D, Huang Z, Zhong S, Cai L. Effect of exosomes derived from human Epstein-Barr virus-positive nasopharyngeal carcinoma cells on lymphangiogenesis and lymph node metastasis. Journal of Southern Medical University. 2020;40(12):1776–1783. doi:10.12122/j.issn.1673-4254.2020.12.12.
   Google Scholar
• Houali K, Wang X, Shimizu Y, et al. A new diagnostic marker for secreted Epstein-Barr virus encoded LMP1 and BARF1 oncoproteins in the serum and saliva of patients with nasopharyngeal carcinoma. Clin Cancer Res. 2007;13(17):4993–5000.17785549
   PubMed Web of Science ®Google Scholar
• Li Z, Zhou Z, Wu X, et al. LMP1 promotes nasopharyngeal carcinoma metastasis through NTRK2-mediated anoikis resistance. Am J Cancer Res. 2020;10(7):2083–2099.32775002
   PubMed Web of Science ®Google Scholar
• Wakae K, Kondo S, Pham HT, et al. EBV-LMP1 induces APOBEC3s and mitochondrial DNA hypermutation in nasopharyngeal cancer. Cancer Med. 2020;9(20):7663–7671. doi:10.1002/cam4.335732815637
   PubMed Web of Science ®Google Scholar
• Gonzalez-Begne M, Lu B, Han X, et al. Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). J Proteome Res. 2009;8(3):1304–1314. doi:10.1021/pr800658c19199708
   PubMed Web of Science ®Google Scholar
• Carbone C, Piro G, Merz V, et al. Angiopoietin-like proteins in angiogenesis, inflammation and cancer. Int J Mol Sci. 2018;19(2):431. doi:10.3390/ijms19020431
   PubMed Web of Science ®Google Scholar
• Jiang K, Chen H, Fang Y, et al. Exosomal ANGPTL1 attenuates colorectal cancer liver metastasis by regulating Kupffer cell secretion pattern and impeding MMP9 induced vascular leakiness. J Exp Clin Cancer Res. 2021;40(1):21. doi:10.1186/s13046-020-01816-333413536
   PubMed Web of Science ®Google Scholar
• Lee BC, Kang I, Yu KR. Therapeutic features and updated clinical trials of Mesenchymal Stem Cell (MSC)-derived exosomes. J Clin Med. 2021;10(4):711. doi:10.3390/jcm1004071133670202
   PubMed Web of Science ®Google Scholar
• Wei JX, Lv LH, Wan YL, et al. Vps4A functions as a tumor suppressor by regulating the secretion and uptake of exosomal microRNAs in human hepatoma cells. Hepatology (Baltimore, Md). 2015;61(4):1284–1294. doi:10.1002/hep.27660
   PubMed Web of Science ®Google Scholar
• Kanlikilicer P, Bayraktar R, Denizli M, et al. Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer. EBioMedicine. 2018;38:100–112. doi:10.1016/j.ebiom.2018.11.00430487062
   PubMed Web of Science ®Google Scholar
• Xu X, Gao F, Wang J, et al. MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4. Cancer Biol Ther. 2018;19(5):427–435. doi:10.1080/15384047.2018.142392529509059
   PubMed Web of Science ®Google Scholar
• Zhang ZR, Yang N. MiR-33a-5p inhibits the growth and metastasis of melanoma cells by targeting SNAI2. Neoplasma. 2020;67(4):813–824. doi:10.4149/neo_2020_190823N81132305057
   PubMed Web of Science ®Google Scholar